{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:37:37Z","timestamp":1780497457826,"version":"3.54.1"},"reference-count":17,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,10,1]]},"DOI":"10.5551\/jat.63874","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T22:11:07Z","timestamp":1675289467000},"page":"1461-1470","source":"Crossref","is-referenced-by-count":7,"title":["Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study"],"prefix":"10.5551","volume":"30","author":[{"given":"Kazuki","family":"Tobita","sequence":"first","affiliation":[{"name":"Department of Cardiology, Shonan Kamakura General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Diabetes Care Medicine and Department of Metabolic Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Kansai Rosai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Matsuyama Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Ichihashi","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Matsuyama Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shonan Kamakura General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","unstructured":"1) Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Rother J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I and Group ESCSD: 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018; 39: 763-816"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Bailey SR, Beckman JA, Dao TD, Misra S, Sobieszczyk PS, White CJ, Wann LS, Bailey SR, Dao T, Aronow HD, Fazel R, Gornik HL, Gray BH, Halperin JL, Hirsch AT, Jaff MR, Krishnamurthy V, Parikh SA, Reed AB, Shamoun F, Shugart RE and Yucel EK: ACC\/AHA\/SCAI\/SIR\/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine. Journal of the American College of Cardiology, 2019; 73: 214-237","DOI":"10.1016\/j.jacc.2018.10.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Feldman DN, Armstrong EJ, Aronow HD, Gigliotti OS, Jaff MR, Klein AJ, Parikh SA, Prasad A, Rosenfield K, Shishehbor MH, Swaminathan RV and White CJ: SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv, 2018; 92: 124-140","DOI":"10.1002\/ccd.27635"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ohki T, Kichikawa K, Yokoi H, Uematsu M, Yamaoka T, Maeda K and Kanaoka Y: Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions. J Vasc Surg, 2017; 66: 130-142 e131","DOI":"10.1016\/j.jvs.2017.01.065"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Iida O, Takahara M, Soga Y, Yamaoka T, Nanto S, Kuratani T, Sakata Y and Mano T: One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study. J Endovasc Ther, 2021; 28: 123-131","DOI":"10.1177\/1526602820960445"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ohki T, Kichikawa K, Yokoi H, Iida O, Yamaoka T, Maeda K and Kanaoka Y: Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery. J Vasc Surg, 2021; 74: 1958-1967 e1952","DOI":"10.1016\/j.jvs.2021.05.056"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R and Schoder M: Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). Journal of the American College of Cardiology, 2013; 62: 1320-1327","DOI":"10.1016\/j.jacc.2013.05.079"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Reijnen M, van Walraven LA, Fritschy WM, Lensvelt MMA, Zeebregts CJ, Lemson MS, Wikkeling ORM, Smeets L and Holewijn S: 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass. JACC Cardiovascular interventions, 2017; 10: 2320-2331","DOI":"10.1016\/j.jcin.2017.09.013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Banerjee S, Sarode K, Mohammad A, Gigliotti O, Baig MS, Tsai S, Shammas NW, Prasad A, Abu-Fadel M, Klein A, Armstrong EJ, Jeon-Slaughter H, Brilakis ES and Bhatt DL: Femoropopliteal Artery Stent Thrombosis: Report From the Excellence in Peripheral Artery Disease Registry. Circulation Cardiovascular interventions, 2016; 9: e002730","DOI":"10.1161\/CIRCINTERVENTIONS.115.002730"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Geng DF, Liu M, Jin DM, Wu W, Deng J and Wang JF: Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients. Cardiology, 2012; 122: 148-157","DOI":"10.1159\/000338812"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Brown T, Forster RB, Cleanthis M, Mikhailidis DP, Stansby G and Stewart M: Cilostazol for intermittent claudication. The Cochrane database of systematic reviews, 2021; 6: Cd003748","DOI":"10.1002\/14651858.CD003748.pub5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Douglas JS, Jr., Holmes DR, Jr., Kereiakes DJ, Grines CL, Block E, Ghazzal ZM, Morris DC, Liberman H, Parker K, Jurkovitz C, Murrah N, Foster J, Hyde P, Mancini GB, Weintraub WS and Cilostazol for Restenosis Trial I: Coronary stent restenosis in patients treated with cilostazol. Circulation, 2005; 112: 2826-2832","DOI":"10.1161\/CIRCULATIONAHA.104.530097"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nanto K, Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T and Uematsu M: Effect of Cilostazol Following Endovascular Intervention for Peripheral Artery Disease. Angiology, 2015; 66: 774-778","DOI":"10.1177\/0003319714551361"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zeller T, Peeters P, Bosiers M, Lammer J, Brechtel K, Scheinert D, Rastan A, Noory E and Beschorner U: Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial. J Endovasc Ther, 2014; 21: 765-774","DOI":"10.1583\/14-4790R.1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Lin TC, Huang CY, Chen PL, Lee CY, Shih CC and Chen IM: Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty. J Endovasc Ther, 2018; 25: 313-319","DOI":"10.1177\/1526602818771345"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, Lopez-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E and Investigators H-: Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med, 2016; 374: 2021-2031","DOI":"10.1056\/NEJMoa1600176"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) de Grijs D, Teixeira P and Katz S: The association of statin therapy with the primary patency of femoral and popliteal artery stents. J Vasc Surg, 2018; 67: 1472-1479","DOI":"10.1016\/j.jvs.2017.09.022"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/10\/30_63874\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T04:39:37Z","timestamp":1696653577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/10\/30_63874\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63874","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,1]]},"article-number":"63874"}}